{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:13:01Z","timestamp":1778911981438,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1245\/s10434-022-12695-7","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T15:10:05Z","timestamp":1666710605000},"page":"1195-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases"],"prefix":"10.1245","volume":"30","author":[{"given":"Elena","family":"Parvez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Khosrow-Khavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Dumitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Nessim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ricka","family":"Bernard-B\u00e9dard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Pravong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Kim","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarkis","family":"Meterissian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinziana","family":"Dumitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"2","key":"12695_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","volume":"25","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: american society of clinical oncology and society of surgical oncology clinical practice guideline update. Ann Surg Oncol. 2018;25(2):356\u201377. https:\/\/doi.org\/10.1245\/s10434-017-6267-7.","journal-title":"Ann Surg Oncol."},{"issue":"23","key":"12695_CR2","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. New Engl J Med. 2017;376(23):2211\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1613210.","journal-title":"New Engl J Med."},{"issue":"6","key":"12695_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757\u201367. https:\/\/doi.org\/10.1016\/S1470-2045(16)00141-8.","journal-title":"Lancet Oncol."},{"key":"12695_CR4","unstructured":"National Comprehensive Cancer Network. Cutaneous Melanoma (Version 3.2022). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf. Accessed 5 July  2022."},{"issue":"9","key":"12695_CR5","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","volume":"21","author":"ZM Bamboat","year":"2014","unstructured":"Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG. Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol. 2014;21(9):3117\u201323. https:\/\/doi.org\/10.1245\/s10434-014-3758-7.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"12695_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jamcollsurg.2020.11.014","volume":"232","author":"KK Broman","year":"2021","unstructured":"Broman KK, Hughes TM, Dossett LA, et al. Surveillance of sentinel node-positive melanoma patients with reasons for exclusion from MSLT-II: multi-institutional propensity score matched analysis. J Am Coll Surg. 2021;232(4):424\u201331. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.11.014.","journal-title":"J Am Coll Surg."},{"issue":"12","key":"12695_CR7","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0.The","volume":"17","author":"MB Faries","year":"2010","unstructured":"Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and lengthof stay of early versus delayed complete lymphadenectomy in melanoma: results of the multicenter selective lymphadenectomy trial (I). Ann Surg Oncol. 2010;17(12):3324\u20139. https:\/\/doi.org\/10.1245\/s10434-010-1203-0.The.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"12695_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1245\/s10434-017-6242-3","volume":"25","author":"LM Postlewait","year":"2018","unstructured":"Postlewait LM, Farley CR, Seamens AM, et al. Morbidity and outcomes following axillary lymphadenectomy for melanoma: weighing the risk of surgery in the era of MSLT-II. Ann Surg Oncol. 2018;25(2):465\u201370. https:\/\/doi.org\/10.1245\/s10434-017-6242-3.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"12695_CR9","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.ejso.2017.07.003","volume":"43","author":"JA Moody","year":"2017","unstructured":"Moody JA, Botham SJ, Dahill KE, Wallace DL. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - a systematic review of the literature. Eur J Surg Oncol. 2017;43(9):1760\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2017.07.003.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"12695_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3747\/co.26.4885","volume":"26","author":"FC Wright","year":"2019","unstructured":"Wright FC, Souter LH, Kellett S, et al. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline. Curr Oncol. 2019;26(4):541\u201350.","journal-title":"Curr Oncol."},{"issue":"8","key":"12695_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamasurg.2017.1025","volume":"152","author":"TS Wahl","year":"2017","unstructured":"Wahl TS, Graham LA, Hawn MT, et al. Association of the modified frailty index with 30-day surgical readmission. JAMA Surg. 2017;152(8):749\u201357. https:\/\/doi.org\/10.1001\/jamasurg.2017.1025.","journal-title":"JAMA Surg."},{"key":"12695_CR12","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) \u2013 A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"12695_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for nonresponse in surveys","author":"D Rubin","year":"1987","unstructured":"Rubin D. Multiple Imputation for nonresponse in surveys. New York: Wiley; 1987."},{"issue":"6","key":"12695_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"A Giuliano","year":"2011","unstructured":"Giuliano A, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA."},{"issue":"11","key":"12695_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaoncol.2018.1908","volume":"4","author":"M Morrow","year":"2018","unstructured":"Morrow M, Jagsi R, Chandler M, Shumway D, Katz SJ. Surgeon attitudes toward the omission of axillary dissection in early breast cancer. JAMA Oncol. 2018;4(11):1511\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1908.","journal-title":"JAMA Oncol."},{"key":"12695_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/ans.15491","volume":"90","author":"AAG Nijhuis","year":"2020","unstructured":"Nijhuis AAG, Spillane AJ, Stretch JR, et al. Current management of patients with melanoma who are found to be sentinel node-positive. Surg Oncol. 2020;90:491\u20136. https:\/\/doi.org\/10.1111\/ans.15491.","journal-title":"Surg Oncol."},{"issue":"6","key":"12695_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/SLA.0b013e31818fefe0","volume":"248","author":"CJ Alexander","year":"2008","unstructured":"Alexander CJ, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 ratients with positive sentinel nodes. Ann Surg. 2008;248(6):949\u201354. https:\/\/doi.org\/10.1097\/SLA.0b013e31818fefe0.","journal-title":"Ann Surg."},{"issue":"3","key":"12695_CR18","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/S1470-2045(19)30099-3","volume":"20","author":"V Franke","year":"2019","unstructured":"Franke V, van Akkooi ACJ. The extent of surgery for stage III melanoma: how much is appropriate? Lancet Oncol. 2019;20(3):e167\u201374. https:\/\/doi.org\/10.1016\/S1470-2045(19)30099-3.","journal-title":"Lancet Oncol."},{"issue":"32","key":"12695_CR19","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.18.02306","volume":"37","author":"U Leiter","year":"2019","unstructured":"Leiter U, Stadler R, Mauch C, et al. Final analysis of decog-slt trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37(32):3000\u20138. https:\/\/doi.org\/10.1200\/JCO.18.02306.","journal-title":"J Clin Oncol."},{"issue":"12","key":"12695_CR20","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1245\/s10434-019-07694-0","volume":"26","author":"M Kwak","year":"2019","unstructured":"Kwak M, Song Y, Gimotty PA, et al. Characteristics associated with pathologic nodal burden in patients presenting with clinical melanoma nodal metastasis. Ann Surg Oncol. 2019;26(12):3962\u201371. https:\/\/doi.org\/10.1245\/s10434-019-07694-0.","journal-title":"Ann Surg Oncol."},{"issue":"35","key":"12695_CR21","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1200\/JCO.18.01219","volume":"36","author":"A Hauschild","year":"2018","unstructured":"Hauschild A, Dummer R, Schadendorf D, et al. Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600\u2013mutant stage III melanoma. J Clin Oncol. 2018;36(35):3441\u20139. https:\/\/doi.org\/10.1200\/JCO.18.01219.","journal-title":"J Clin Oncol."},{"issue":"19","key":"12695_CR22","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. New Engl J Med. 2017;377(19):1824\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1709030.","journal-title":"New Engl J Med."},{"issue":"2","key":"12695_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jnci\/djq455","volume":"103","author":"Y Xing","year":"2011","unstructured":"Xing Y, Bronstein Y, Ross MI, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103(2):129\u201342. https:\/\/doi.org\/10.1093\/jnci\/djq455.","journal-title":"J Natl Cancer Inst."},{"issue":"11","key":"12695_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.11621","volume":"107","author":"EK Bartlett","year":"2020","unstructured":"Bartlett EK, Lee AY, Spanheimer PM, et al. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. Br J Surg. 2020;107(11):1480\u20138. https:\/\/doi.org\/10.1002\/bjs.11621.","journal-title":"Br J Surg."},{"key":"12695_CR25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08407-8","author":"AM Ibrahim","year":"2020","unstructured":"Ibrahim AM, May ML, Bosse D. Imaging intensity and survival outcomes in high-risk resected melanoma treated by systemic therapy at recurrence. Ann Surg Oncol. 2020. https:\/\/doi.org\/10.1245\/s10434-020-08407-8.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"12695_CR26","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1245\/s10434-020-08633-0","volume":"27","author":"MG Neuwirth","year":"2020","unstructured":"Neuwirth MG. Timing is everything: could surveillance imaging intensity influence survival in high-risk melanoma? Ann Surg Oncol. 2020;27(10):3577\u20138. https:\/\/doi.org\/10.1245\/s10434-020-08633-0.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12695-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12695-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12695-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:05:37Z","timestamp":1672668337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12695-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["12695"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12695-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}